Association of Low Fasting Glucose and HbA1c With Cardiovascular Disease and Mortality: The MESA Study
暂无分享,去创建一个
Dorothy D. Sears | M. Szklo | A. Bertoni | D. Sears | C. Anderson | S. Golden | N. Mathioudakis | Morgana Mongraw-Chaffin
[1] J. Manson,et al. HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women , 2008, Diabetologia.
[2] Michael E. Miller,et al. Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.
[3] T. Jørgensen,et al. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study , 2010, Diabetologia.
[4] Michael E. Miller,et al. ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY GROUP. EFFECTS OF INTENSIVE GLUCOSE LOWERING IN TYPE 2 DIABETES , 2010 .
[5] W. Post,et al. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). , 2011, Journal of the American College of Cardiology.
[6] Yuli Huang,et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis , 2016, British Medical Journal.
[7] J. Kampert,et al. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. , 2000, Circulation.
[8] W. Rathmann,et al. HbA1c levels in non-diabetic older adults – No J-shaped associations with primary cardiovascular events, cardiovascular and all-cause mortality after adjustment for confounders in a meta-analysis of individual participant data from six cohort studies , 2016, BMC Medicine.
[9] A. Morris,et al. Both High and Low HbA1c Predict Incident Heart Failure in Type 2 Diabetes Mellitus , 2015, Circulation. Heart failure.
[10] P. Macfarlane,et al. Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. , 2010, European heart journal.
[11] S. Yusuf,et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.
[12] J. Danesh,et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. , 2010, Lancet.
[13] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[14] G. L. Moneta. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2011 .
[15] A. Kautzky-Willer,et al. Gender‐based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient‐level pooled data of six randomized controlled trials , 2015, Diabetes, obesity & metabolism.
[16] F. Cavalot. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes , 2013, Diabetes, obesity & metabolism.
[17] Jennifer Y. Liu,et al. Glycemic Control, Complications, and Death in Older Diabetic Patients , 2011, Diabetes Care.
[18] D. Tanné,et al. Fasting Plasma Glucose and Risk of Incident Ischemic Stroke or Transient Ischemic Attacks: A Prospective Cohort Study , 2004, Stroke.
[19] J. C. Kuenen,et al. Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study , 2010, Diabetologia.
[20] Hiroyuki Yanagisawa,et al. Association between HbA1c variability and mortality in patients with type 2 diabetes. , 2014, Journal of diabetes and its complications.
[21] J. Pankow,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.
[22] Wang-Dong Xu,et al. Analysis of blood glucose distribution characteristics in a health examination population in Chengdu (2007–2015) , 2017, Medicine.
[23] M. Gulliford,et al. Recent HbA1c Values and Mortality Risk in Type 2 Diabetes. Population-Based Case-Control Study , 2013, PloS one.
[24] Dorothy D. Sears,et al. A prospective study of low fasting glucose with cardiovascular disease events and all-cause mortality: The Women's Health Initiative. , 2017, Metabolism: clinical and experimental.
[25] N. Day,et al. Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.
[26] Y. Iwamoto,et al. Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetes , 2011, Journal of diabetes investigation.
[27] R. Heine,et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study , 2010, The Lancet.
[28] L. Arnold,et al. The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies. , 2014, The review of diabetic studies : RDS.
[29] J. Samet,et al. Fasting Glucose Level and the Risk of Incident Atherosclerotic Cardiovascular Diseases , 2013, Diabetes Care.
[30] E. Selvin,et al. Low hemoglobin A(1c) in nondiabetic adults: an elevated risk state? , 2012, Diabetes care.
[31] C. Fox,et al. Low Hemoglobin A1c and Risk of All-Cause Mortality Among US Adults Without Diabetes , 2010, Circulation. Cardiovascular quality and outcomes.
[32] V. Beral,et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents , 2016, The Lancet.
[33] Chia-Ing Li,et al. Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes. , 2012, The American journal of medicine.